10 things to know about ECR president | New contrast kid in town | CT algorithm shows promise

Dear AuntMinnieEurope Member,

Since ECR switched to Vienna in 1991, the congress presidents have been leading European radiologists. Also, they've never been dull, functionary types in gray suits. This has enlivened successive meetings -- and made the media's job easier and more interesting.

The ECR 2017 president looks set to uphold this tradition. Dr. Paul Parizel, PhD, is a gracious, eloquent, and cultured person who has strong and lively views and isn't afraid of expressing them. To read a personal profile of him, go to the CT Community, or click here. And look out for the second part of our interview next week.

The European Medicines Agency's ongoing and much delayed investigation into gadolinium-based MR contrast agents has created huge uncertainty over the last year. Partly due to this regulatory haze, it looks like manganese-based contrast products may someday replace gadolinium agents, at least for selected indications, writes Dr. Peter Rinck, PhD, in his latest column. Visit our MRI Community, or click here.

Until recently, techniques such as iterative CT reconstruction were only available for applications like low-dose diagnostic CT, but it's now becoming available for CT fluoroscopy as well, according to new German research. Get the full story here.

Meanwhile, Italian researchers have found that combining lung and venous ultrasound, Wells score, and D-dimer test results can help avoid the need to perform CT pulmonary angiography in half of cases with suspected pulmonary embolism. To read more, click here.

A well-known figure in the development of MRI, Sir Peter Mansfield, PhD, died last week. He shared the 2003 Nobel Prize for Medicine and Physiology with Paul Lauterbur, PhD. Click here for the full details. And to remind yourself how the long-running dispute over the prize resurfaced at ECR 2014, click here.

Page 1 of 1264
Next Page